抗菌剂
加药
抗菌管理
重症监护医学
抗生素耐药性
抗菌药物
药品
生物
药效学
抗药性
风险分析(工程)
药理学
医学
抗生素
药代动力学
微生物学
作者
Timothy M. Rawson,Richard Wilson,Dermot O’Hare,Pau Herrero,Andrew Kambugu,Mohammed Lamorde,Matthew J. Ellington,Pantelis Georgiou,Anthony E. G. Cass,William Hope,Alison Holmes
标识
DOI:10.1038/s41579-021-00578-9
摘要
An optimal antimicrobial dose provides enough drug to achieve a clinical response while minimizing toxicity and development of drug resistance. There can be considerable variability in pharmacokinetics, for example, owing to comorbidities or other medications, which affects antimicrobial pharmacodynamics and, thus, treatment success. Although current approaches to antimicrobial dose optimization address fixed variability, better methods to monitor and rapidly adjust antimicrobial dosing are required to understand and react to residual variability that occurs within and between individuals. We review current challenges to the wider implementation of antimicrobial dose optimization and highlight novel solutions, including biosensor-based, real-time therapeutic drug monitoring and computer-controlled, closed-loop control systems. Precision antimicrobial dosing promises to improve patient outcome and is important for antimicrobial stewardship and the prevention of antimicrobial resistance.
科研通智能强力驱动
Strongly Powered by AbleSci AI